A ntibiotics are the most commonly prescribed medications among nursing home residents, with approximately twothirds of residents receiving antibiotic treatment each year. [1] [2] [3] Many of these prescriptions are inappropriate, unnecessary, or unnecessarily prolonged, thereby directly exposing individual recipients to Clostridium difficile infection and diarrhea, antibiotic-resistant organisms, antibiotic allergies, and other medication toxic effects. 1, [4] [5] [6] By promoting selection of C difficile and antibiotic-resistant organisms, antibiotic overuse also poses a potential indirect threat beyond the recipients of these medications because these pathogens can lead to environmental contamination and cross-transmission among residents.
We have previously reported that the variation of antibiotic treatment duration in nursing homes is more dependent on prescriber than recipient characteristics. 6 Because most nursing home prescribers in Ontario, Canada, are associated with a single nursing home, 7 we hypothesized that antibiotic use would also vary across homes. The capacity of antibiotic treatments to harm individual recipients and neighboring nursing home residents implies that residents could be subject to a higher risk of antibiotic-related adverse outcomes purely on the basis of their place of residence. 8 Measuring antibiotic use at the nursing home level is also useful because antibiotic stewardship interventions and solutions could potentially be introduced at that level. [9] [10] [11] The objectives of this longitudinal open-cohort study were to measure the variability in antibiotic use across Ontario nursing homes and to determine whether residence within a nursing home with high antibiotic use is associated with a greater risk of antibiotic-related adverse outcomes for individual residents.
Methods

Study Design and Data Sources
The study was approved by the research ethics board of Sunnybrook Health Sciences Centre. Informed consent was not required. The study was conducted in the most populous province of Ontario, Canada, using population-based administrative databases at the Institute for Clinical Evaluative Sciences. These well-validated databases are linked through encoded health care numbers and have been used extensively in prior research of medication use in general [12] [13] [14] and antibiotic prescribing in particular. 6, 15 These data sets include the following: (1) the Registered Persons database, which contains demographic data for all users of Ontario's universal single-payer health care system; (2) the Continuing Care Reporting System Long-Term Care database generated from the Resident Assessment Instrument Minimum Data Set 2.0, a mandatory resident assessment completed at quarterly intervals 16 ; (3) the Ontario Drug Benefit Program database, which contains detailed drug information for Ontario's more than 1.5 million older adults; (4) the Ontario Health Insurance Plan database, which includes physician billing claims; (5) the Canadian Institute for Health Information Discharge abstract database, which details all hospitalization events; (6) the Ontario Mental Health Reporting System database, which documents admissions to designated psychiatric beds; (7) the National Ambulatory Care Reporting System database, which describes all emergency department visits; and (8) the National Rehabilitation Reporting System.
Resident Selection Criteria
The cohort consisted of all older adults (aged ≥66 years) residing in an Ontario nursing home from January 1, 2010, through December 31, 2011. We excluded the residents who were younger than 66 years, stayed only in homes with fewer than 25 beds, or switched homes more than once during the study.
Deriving the Open Cohort of Resident Time Spent in Nursing Homes
Residents of nursing homes are often transferred to the emergency department or hospital. This time spent out of the nursing home poses a methodologic challenge for studies of exposures introduced within nursing homes. To address this issue, we created an open cohort, which allowed us to calculate all resident-days spent in Ontario nursing homes. All residents were followed up from January 1, 2010, or their new arrival into a nursing home (whichever came last) until December 31, 2011, or death (whichever came first). Time intervals spent in nursing homes were considered at risk and contributed to the denominator of resident-days in which an individual was eligible to receive an antibiotic. Time intervals spent outside the nursing home were considered off risk, including time spent in the emergency department, acute care facility, psychiatric facility, chronic care facility, and/or rehabilitation hospitals. If, during the study period, a resident returned to the nursing home from one of these alternate locations, the resident could continue to contribute resident-days to the cohort. A small proportion of residents (7.0%) were transferred between different homes during the study period, and the corresponding resident time was apportioned separately to these facilities. To cross-validate the accuracy of our at-risk intervals, we reviewed the proportion of intervals that included at least one drug claim identified as being dispensed to a nursing home resident. Our cross-validation confirmed that 99.5% of these atrisk intervals were associated with at least one such claim.
Antibiotic Use
Consistent with previous work, dispensed antibiotics were ascertained from the Ontario Drug Benefit Program database, which includes information on drug name, drug dose, drug route, date of drug claim, days supplied, and prescription location. 6, 15 This program provides universal coverage of publicly funded medications for all Ontario adults older than 65 years; the database is greater than 99% concordant with pharmacy medical record review. 17 We included all systemic antibacterials administered via the enteral or parenteral route; we excluded antifungals, antivirals, and topical agents. 15 
Variability in Antibiotic Use
Antibiotic use was calculated as the number of days a resident received antibiotics per 1000 at-risk resident-days spent in each home. The primary predictor of interest was nursing home-level antibiotic use during the study interval, categorized in tertiles as low, medium, or high use.
vs rural) 21, 22 because these facility structural characteristics are known to be associated with antibiotic use and/or medicationrelated adverse events.
Resident Factors
Detailed resident-level factors were collected from the Continuing Care Reporting System Long-term Care database, as well as hospital, emergency department, and physician claims databases. 6 The Continuing Care Reporting System assessments are performed using the Resident Assessment Instrument Minimum Data Set 2.0, which provides a comprehensive, wellvalidated assessment of the functional status and care needs of nursing home residents. 16 Resident factors that could potentially affect the need for antibiotics or vulnerability to antibiotic-related complications included extensive demographic data, nursing home experience, health care use, diagnoses, functional dependence, continence, and device use variables.
1,2,23,24
Antibiotic-Related Adverse Outcomes
The primary outcome was a composite of potential antibioticrelated adverse outcomes, including C difficile, diarrhea or gastroenteritis, antibiotic-resistant organisms, allergic reactions to antibiotics, or general medication adverse events. Each component outcome was detected through International Statistical Classification of Diseases, 10th Revision (ICD-10), codes from hospital admission and emergency department databases (eTable in the Supplement). The available ICD-10 codes for antibiotic resistance include methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, extendedspectrum β-lactamase-producing Gram-negative bacteria, and more broad codes for resistance to β-lactams, fluoroquinolones, or multiple antibiotic classes (eTable in the Supplement). The hospital and emergency department databases have been validated through extensive medical record reabstraction studies, but the adverse drug reaction codes were not specifically examined. The accuracy of C difficile coding has been validated separately, with excellent test characteristics. [25] [26] [27] Diarrhea or gastroenteritis was also measured through outpatient physician billing claims to capture antibiotic-associated diarrhea and C difficile infections that did not require hospitalization because there are no specific physician claims for these entities. Residents with a do-not-hospitalize order were excluded from all outcome analyses; by definition, they are not at risk of hospitalization outcome events. A nested secondary outcome measure included only those events that have the potential to cause direct harm to recipients and indirect harm through transmission to other residents (C difficile, diarrhea or gastroenteritis, and antibiotic-resistant organisms). All outcomes were measured at the level of individual residents.
Statistical Analysis
Baseline nursing home and resident characteristics were compared across tertiles of nursing home antibiotic use. Crude primary and secondary outcome rates were calculated across these same tertiles. The primary outcome rate was also examined among the subset of nursing home residents who never directly received an antibiotic. The primary analysis involved a multivariable marginal (nonconditional) logistic regression analysis, assessing the affect of nursing home-level antibiotic use tertile on the resident-level risk of an antibiotic adverse event. These models accounted for all the other measured nursing home-level and resident-level characteristics, as well as for clustering within homes. Similar modeling was performed for the secondary outcome measure, which was limited to complications that could affect antibiotic recipients and nonrecipients. We compared high-use and low-use nursing homes because recent literature suggests that interfacility comparisons should focus on extreme tiers rather than intermediate tiers 28 ; this approach also protects against multiple hypothesis testing. In a sensitivity analysis, we examined nursing home-level antibiotic use as a continuous variable. All analyses were performed using SAS statistical software, version 9.3 (SAS Institute Inc). The classes of antibiotic agents were similar across the facilities, with penicillins being the most commonly prescribed agents in low-, medium-, and high-use facilities (32.6%, 33.5%, and 33.7% of antibiotic prescriptions, respectively), followed by second-generation fluoroquinolones (31.7%, 29.4%, and 27.1% of antibiotic prescriptions, respectively). Sulfonamides, first-generation cephalosporins, nitrofurantoin, and macrolides were the next most common classes of antibiotics, each accounting for 4% to 9% of antimicrobial prescriptions in each tertile. However, there were more antibiotic prescriptions in the high-vs medium-vs low-use facilities (191 
Results
Variability in Antibiotic Use Across Nursing Homes
Nursing Home and Resident Characteristics
The median number of beds across nursing homes was 120 (interquartile range, 75-160 beds). Most nursing homes were in urban centers (473 [77.9%]) and had for-profit ownership (378 [62.3%]). In general, high-use facilities were smaller, more likely to have for-profit ownership, and more likely to be rural ( Table 1) .
Nursing Home Antibiotic Use and the Risk of Antibiotic-Related Adverse Events for Residents
The risk of an antibiotic-related adverse event was higher in residents of high-use (3311 [13 11 880) (P = .02). The number needed to harm was 71 for direct antibiotic recipients and 83 for nonrecipients. The secondary outcome measure restricted to the subset of complications that can potentially affect recipients and nonrecipients of antibiotics also occurred at a higher rate among residents of the highest-use tertile. For some of the less common individual adverse events, statistically significant differences were not detected across the tertiles (Table 3) .
Multivariable logistic regression modeling of the primary outcome indicated that residence in a high-use (compared with low-use) home was associated with an increased risk of experiencing any antibiotic-related adverse event (adjusted odds ratio [aOR], 1.24; 95% CI, 1.07-1.42; P = .003) ( Table 4) . Other important predictors of antibiotic-related complications included previous hospitalization and emergency department visits, diabetes mellitus, peripheral vascular disease, cancer, gastrointestinal disease, liver disease, renal failure, func- 
Discussion
This study of more than 100 000 older residents of more than 600 nursing homes confirmed a 10-fold variation in nursing home antibiotic use. Residents of high-use nursing homes were exposed to a 24% greater risk of antibiotic-related adverse events, including emergency department visits and hospitalizations related to C difficile infections, diarrhea or gastroenteritis, antibiotic-resistant organisms, allergies, and general medication adverse events. Each additional day of antibiotic use in a facility is associated with a 0.4% increased risk of an antibiotic-related harm for a resident. High antibiotic use in a facility is associated with increased individual-level risk, even among nonrecipients of antibiotics.
The high variability of antibiotic use across nursing homes corroborates our previous finding of high variability in the use of prolonged antibiotic treatment durations in nursing homes, likely driven by culture and prescriber preference rather than resident characteristics. 6 Our results are in line with work by the European Surveillance of Antimicrobial Consumption, which revealed that the point prevalence of antibiotic use in nursing homes varies within and between European countries from as low to 1% to as high as 35% of residents, 29 as well as a multijurisdiction sampling of 73 US nursing homes that indicated a variation in the number of antibiotic courses prescribed from 0.44 to 23 per 1000 resident-days. 30 Our study extends these findings by generating an open cohort of person time spent in nursing homes to calculate antibiotic use per resident time in a manner similar to the way density of antibiotic use is measured in acute care facilities. 18, 31 More importantly, our study extends prior research by linking antibiotic variability to an increased risk of harms for residents. Our group and others 12, 13 have previously found that use of antipsychotics and benzodiazepines in older nursing home residents is associated with serious harms to the recipients of these unsafe medications. The harms of antibiotics, however, threaten not only individual recipients but also neighboring and future residents given the exertion of a selective pressure on the local microbial ecology, leading to higher rates of antibiotic-resistant pathogens and C difficile. Our multivariable analysis of nursing home-and residentlevel characteristics confirmed a number of other expected predictors of increased vulnerability to antibiotic-related harms, including advanced age, previous health care use, diabetes mellitus, peripheral vascular disease, liver and renal disease, and use of indwelling devices. Resident-level factors associated with a reduced risk of antibiotic-related harms included a do-not-resuscitate order and dementia, perhaps because of a lower propensity to subject these patients to aggressive diagnostics and treatment. Some other nursing home-level characteristics were associated with an increased risk of antibiotic-related harms. Larger facilities were associated with more adverse events, potentially related to increased crowding and interpatient transmission of pathogens.
1 Rural facilities were overrepresented in the highest tertile of antibiotic use, but after accounting for other nursing home-and patient-level characteristics, rurality was found to be protective against antibiotic-related harms. The mechanism for this protective association of rurality may be an artifact related to hospital access but merits further study. 1 Our study is subject to limitations from the use of administrative databases, but misclassification of antibiotic use is highly unlikely given the accuracy of the Ontario Drug Benefit Program database. 17 In addition, misclassification of resident characteristics is unlikely in the well-validated Resident Assessment Instrument Minimum Data Set 2.0 database, 16 and accurate assignment of resident time in nursing homes was confirmed by 99.5% cross-agreement between the independent nursing home and drug data sets. Moreover, any misclassification in hospital and emergency department outcome databases should be nondifferential for residents of low-and high-use nursing homes, and so we may have underestimated the magnitude of risk associated with high antibiotic use. Given the lack of inpatient medication data in the hospital data sets, our study cannot account for potential harms that originate from antibiotics received during off-risk exposure times. Our outcome definition likely undercounts antibiotic-resistant organisms and will miss mild-moderate antibiotic harms that do not result in emergency department visits or hospitalization, but this fact only further supports the clinical relevance of the number needed to harm estimate of 53 residents because these events were serious enough to prompt transfer to an emer- a Residents with a do-not-hospitalize order were excluded from these analyses of adverse outcomes because they were not at risk of a hospitalization event. b Includes any of C difficile, diarrhea or gastroenteritis, antibiotic-resistant organisms, allergy, and general medication adverse events. c Includes only C difficile, diarrhea or gastroenteritis, and antibiotic-resistant organisms.
gency department or hospital. We cannot assess the appropriateness of antibiotic use given that medical record review is beyond the scope of a study of this size, but the consistent finding of inappropriate antibiotic use in previous related nursing home research suggests that the variability of antibiotic use across institutions in a large part relates to variabil- 
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In the United States, on any given day, approximately 1.4 million people reside in more than 15 000 nursing homes (NHs). 1 As a testament to the burgeoning post-acute care population, approximately 3.3 million Medicare recipients are admitted to NHs for short stays each year, making NHs a crucial segment of the overall health care provision system within the United States. 2 Antibiotics are one of the most frequently prescribed medications in NHs where 6% to 10% of residents are taking antibiotics at any given time and more than half receive at least one antibiotic prescription in a single year. 3 Much of this use is inappropriate. An estimated 25% to 75% of antibiotic prescriptions do not meet clinical guidelines for appropriate prescribing. 3 The most common infection leading to inappropriate antibiotic therapy is suspected urinary tract infection, which accounts for 30% to 56% of antibiotics prescribed, with up to a third of these prescribed for NH residents with asymptomatic bacteriuria. 4 It is well established that antibiotic use is associated with a number of potential treatment-related harms when assessed at the level of the individual NH resident, including Clostridium difficile infection, adverse drug reactions, and an increased risk of colonization and infection with multidrug-resistant organisms. Documenting direct evidence of the harms of antibiotic use at the population level has proven challenging. Therefore, the article by Daneman et al 5 in this issue of JAMA Internal Medicine is a welcome addition to the field. In this 2-year study of 110 000 NH residents in Ontario, Canada, participants residing in facilities with high rates of antibiotic use were significantly more likely to experience an antibiotic-related harm whether or not they had recently received an antibiotic. On the basis of their findings, the authors predict that one additional antibiotic-related harm is generated for every 53 patients admitted to a high-use compared with low-use NH. Assuming similar patterns of antibiotic use and population-level effects in US NHs, the results of this study suggest that nearly 20 000 individuals experience an antibiotic-related harm simply through residence in NHs with high rates of antibiotic use. 5 Antibiotic-related harms in this study were most commonly identified through administrative records generated during hospital admissions and emergency department visits and less commonly through outpatient practitioner billing records. Consequently, the results of the study likely represent and underestimate the effect of antibiotic overuse in NHs. The study by Daneman et al has a number of methodologic strengths. The authors merged information from multiple administrative data sets to create a robust cohort of nearly 110 000 residents in 607 Ontario NHs with a follow-up of 51 million days. As a result, the authors were 
